Exxon Benzene Verdict: Pennsylvania Appeals Court Upholds $816 Million Leukemia Judgment

The Superior Court of Pennsylvania on October 15, 2026, affirmed the Exxon benzene verdict in Gill v. Exxon Mobil Corp., leaving ExxonMobil liable for a judgment of about $815.8 million to a former Mobil service station mechanic whose acute myeloid leukemia a Philadelphia jury tied to benzene in gasoline. A split three-judge panel held that ExxonMobil had failed to preserve most of its causation arguments at trial and that the trial court acted within its discretion in refusing to cut what plaintiffs' counsel describe as the largest benzene verdict on record and the largest compensatory award in Pennsylvania history.

The decision, docketed at No. 2811 EDA 2024, was reported the same day by The Legal Intelligencer and Law360 and confirmed by the Washington Legal Foundation, which had filed an amicus brief on ExxonMobil's side. It comes two days after a different Philadelphia jury returned a mostly favorable verdict for Exxon in another gasoline-leukemia case, and a month after the first benzene sunscreen trial in the same courthouse ended in a defense verdict. For the plaintiffs' bar, the ruling confirms that a Philadelphia benzene verdict can survive appellate review intact. For defendants and their insurers, the lesson is procedural as much as substantive: arguments that are not preserved in the trial court are, in practice, gone.

What did the Pennsylvania Superior Court decide in Gill v. Exxon Mobil?

The Superior Court affirmed the judgment in full. According to the Washington Legal Foundation's summary and the plaintiffs' firms' accounts, the panel rejected ExxonMobil's challenges to the proof of medical causation, to the admission of the plaintiffs' causation experts, to the size of the compensatory award, and to the conduct of a juror. Most of the causation arguments failed on waiver: the court found that ExxonMobil had not raised them properly before the trial court, and an appellate court in Pennsylvania will not consider a theory raised for the first time on appeal.

On the expert-testimony issue that ExxonMobil did preserve, the panel found no demonstrated abuse of discretion by the trial judge in admitting the plaintiffs' medical causation opinions. On damages, HarrisMartin reports that the court found the trial court acted within its discretion in deeming the award not excessive. Waters Kraus Paul & Siegel, co-counsel for the Gills, describes the majority as declining to substitute its judgment for that of the jury and the trial court on the amount of damages.

The panel was not unanimous. Mealey's describes the ruling as a split decision, and Waters Kraus refers to the result as the view of "a majority" of the panel. Published reports to date do not identify which judge dissented or summarize the dissent's reasoning, and the memorandum itself had not been widely circulated as of October 20.

How much is the Exxon benzene verdict worth now?

The judgment stands at roughly $815.8 million. That figure has two components: the jury's May 2024 verdict of $725.5 million, and about $90 million in delay damages that Philadelphia Court of Common Pleas Judge Carmella Jacquinto added in September 2024 when she denied ExxonMobil's post-trial motions. Of the verdict, $725 million compensated Paul Gill for his injuries and $500,000 compensated his wife, Diane Gill, for loss of consortium.

The award is entirely noneconomic. The jury awarded no punitive damages and no economic damages such as medical expenses or lost earnings, a point the Pennsylvania Record and the Washington Legal Foundation both emphasize. That structure matters: it is why reform groups treated the case as a referendum on pain-and-suffering awards rather than on punishment, and why the federal due-process framework that caps punitive ratios had no direct application to the appeal.

Stage	Date	Forum	Result
Exposure	Second half of the 1970s	Mobil service station	Gill works as a mechanic and attendant handling gasoline and solvents
Diagnosis	2019	n/a	Gill diagnosed with acute myeloid leukemia
Complaint filed	2020	Philadelphia Court of Common Pleas (Case ID 200501803)	Gill v. ExxonMobil et al.
Jury verdict	May 2024	Philadelphia Court of Common Pleas	10-2 verdict, $725.5 million ($725 million + $500,000 consortium)
Post-trial ruling	September 2024	Judge Carmella Jacquinto	Post-trial motions denied; about $90 million in delay damages; judgment about $815.8 million
Amicus briefs	June 2025	Superior Court of Pennsylvania	Chamber coalition, WLF, NAM, DRI, Atlantic Legal Foundation and ATRA support ExxonMobil
Appellate decision	October 15, 2026	Superior Court, No. 2811 EDA 2024	Split panel affirms in full

Post-judgment interest will keep the number climbing. Pennsylvania judgments generally accrue interest at the statutory legal rate of 6 percent per year, which on a judgment of this size works out to roughly $49 million a year, or about $134,000 a day, until the judgment is paid or reversed. That cost is one reason defendants in large Pennsylvania cases often weigh settlement seriously after an intermediate appellate loss.

Why did Exxon lose its appeal of the $816 million benzene judgment?

ExxonMobil lost chiefly because of issue preservation. Every report on the decision, including those from the business amici, identifies waiver as the dominant ground: the company's strongest attacks on causation were not presented to the trial judge in the form it pressed on appeal, so the Superior Court declined to reach them.

Pennsylvania applies preservation rules strictly. Under Pennsylvania Rule of Appellate Procedure 302(a), issues not raised in the lower court are waived and cannot be raised for the first time on appeal. In civil jury cases, Rule of Civil Procedure 227.1 adds a second filter: post-trial motions must be filed within 10 days of the verdict, and grounds not raised at trial and in those motions are generally lost. The Pennsylvania Record reports that both Judge Jacquinto and the Superior Court found ExxonMobil's arguments about a juror's conduct were raised after that 10-day window closed.

The remaining merits challenges ran into deferential standards of review. Admission of expert testimony is reviewed for abuse of discretion. A trial court's refusal to grant a new trial or remittitur on excessiveness grounds is likewise reviewed for abuse of discretion, and Pennsylvania appellate courts traditionally disturb a compensatory award only when it is so excessive that it shocks the sense of justice. With most legal arguments waived, ExxonMobil was left asking the panel to second-guess discretionary calls, which a majority declined to do.

The causation fight

At trial and in post-trial briefing, ExxonMobil contested whether the plaintiffs' experts could reliably link Gill's workplace exposure to his AML. ExxonMobil and amici including DRI and the Atlantic Legal Foundation, in briefs filed in June 2025, argued among other things that the trial court should have held a Frye hearing before letting the plaintiffs' causation experts testify, and that the trial court relied on the plaintiffs' expert evidence without considering the defense experts when it denied a new trial. Pennsylvania still applies the Frye "general acceptance" standard rather than federal Daubert analysis, so the scope of what a trial judge must screen is narrower than in a federal Daubert Challenge. The appellate result means the jury's resolution of General Causation and Specific Causation stands.

Who is Paul Gill and what happened to him?

Paul Gill worked as a mechanic and gas station attendant at a Mobil service station in the second half of the 1970s, where he handled gasoline and benzene-containing solvents. Sources differ on the precise years, giving either 1974 to 1979 or 1975 to 1980. He was diagnosed with acute myeloid leukemia in 2019 and sued in 2020; his wife, Diane, joined with a loss of consortium claim.

The Gills were represented by Locks Law Firm and Waters Kraus Paul & Siegel. The jury found ExxonMobil, as successor to Mobil Oil, negligent, found its gasoline defectively designed, and found a Failure to Warn about the benzene it contained. According to plaintiffs' counsel, an ExxonMobil corporate witness testified at trial that the company had been aware of benzene's hazards since at least 1950. The jury deliberated roughly a full day before returning its 10-2 verdict, the minimum agreement Pennsylvania requires in a civil case (five-sixths of the jurors).

After the verdict, ExxonMobil called it "irrational" and said it would seek reversal. No statement from the company on the October 15 decision had been reported as of October 20.

Does benzene in gasoline cause leukemia?

Benzene is classified by the International Agency for Research on Cancer as a Group 1 carcinogen, known to cause cancer in humans, and the association with acute myeloid leukemia is the most firmly established link. That general classification is not contested in most benzene cases. What is contested is dose: whether a particular plaintiff's exposure, often decades earlier, was high enough to cause his or her specific leukemia.

Gasoline itself contains benzene. Since 2011, federal rules under the Environmental Protection Agency's mobile source air toxics program have required refiners to hold gasoline to an annual average benzene content of 0.62 percent by volume; historical gasoline, including the fuel Gill handled in the 1970s, often contained more. Benzene-containing solvents used for parts cleaning in that era added further exposure for mechanics.

Benzene cases therefore turn on exposure reconstruction and dose-response testimony rather than on whether benzene can cause AML at all. That is precisely the terrain on which ExxonMobil's waived arguments would have been fought, and the reason the waiver ruling carried so much weight.

The amicus fight over noneconomic damages

Business and defense groups filed heavily in the Superior Court. A coalition brief led by the U.S. Chamber of Commerce and joined by the Pennsylvania Chamber of Business and Industry, the Pennsylvania Coalition for Civil Justice Reform and others, alongside a Washington Legal Foundation brief prepared by Robert M. Palumbos and Ryan F. Monahan of Duane Morris LLP, argued that an award consisting only of noneconomic damages, with no punitive or economic component, exemplified a trend of runaway pain-and-suffering awards in Pennsylvania. The National Association of Manufacturers filed in June 2025, and DRI, the Atlantic Legal Foundation and the American Tort Reform Association also appeared.

The panel was not persuaded. The Washington Legal Foundation called the affirmance a setback. Plaintiffs' counsel described it as confirmation that the verdict rested on the evidence.

The fight is not isolated. The Pennsylvania Supreme Court is already reviewing the record $207.6 million birth-injury judgment against the Hospital of the University of Pennsylvania in Hagans, where the Chamber has also filed. Philadelphia has appeared repeatedly on the American Tort Reform Association's "Judicial Hellholes" list, and the Gill affirmance will feature in the next round of that debate.

Can Exxon appeal the benzene verdict to the Pennsylvania Supreme Court?

Yes, but review is discretionary. ExxonMobil can ask the Superior Court to reconsider through an application for reargument, which under Pennsylvania Rule of Appellate Procedure 2542 is ordinarily due within 14 days of the decision, or it can file a petition for allowance of appeal with the Pennsylvania Supreme Court, which under Rule 1113 is ordinarily due within 30 days of the Superior Court's order. On the October 15 decision date, that points to mid-November 2026.

The Supreme Court grants allowance of appeal only for special and important reasons, such as a conflict among Superior Court decisions, a question of first impression, or an issue of substantial public importance. A petition here would likely press two themes: whether noneconomic damages of this magnitude require closer appellate scrutiny, and whether the Superior Court applied waiver too broadly to the causation arguments. The waiver holding is a hurdle in its own right, because the Supreme Court is unlikely to reach a merits question that the intermediate court found was never properly preserved.

The split panel helps ExxonMobil somewhat: a dissent gives a petition a ready-made argument that reasonable jurists disagree. A pending allocatur grant in a related area, such as Hagans, can also lead the Supreme Court to hold a petition until it decides the earlier case.

What are delay damages in Pennsylvania?

Delay damages under Pennsylvania Rule of Civil Procedure 238 are added to a plaintiff's compensatory award in bodily injury, death and property damage cases to account for the time between suit and verdict. They run at the prime rate listed in the first Wall Street Journal edition of each calendar year plus one percentage point, not compounded, generally starting one year after original process is served and ending at the verdict.

A defendant can stop the clock by making a written settlement offer that the plaintiff's eventual recovery does not exceed by more than 25 percent, and periods of delay caused by the plaintiff are excluded. In Gill, Rule 238 added roughly $90 million, about 12 percent on top of the verdict, which reflects both the size of the award and the four years between the 2020 filing and the 2024 verdict.

The Exxon benzene verdict in context: Gill, Mazza and Neutrogena

The Gill affirmance sits beside two recent Philadelphia jury results that cut the other way, which is why reading it as a trend toward plaintiffs would overstate the picture.

Case	Forum	Date	Product	Outcome
Gill v. Exxon Mobil Corp.	Superior Court of Pennsylvania (appeal from Phila. CCP)	October 15, 2026	Mobil gasoline and solvents	$815.8 million judgment affirmed
Mazza v. Exxon Mobil (as reported)	Philadelphia Court of Common Pleas	October 13, 2026	Gasoline	Jury found no design defect and no intentional concealment, though it found an inadequate warning
Neutrogena aerosol sunscreen trial (Quinn and Skaroff estates)	Philadelphia Court of Common Pleas	September 15, 2026	Aerosol sunscreen	Defense verdict; jury found products not defective

According to the Pennsylvania Record, the Mazza jury, hearing claims by Leon and Ruth Mazza, who were also represented by Locks Law Firm, found ExxonMobil's gasoline was not defectively designed and that the company did not intentionally conceal benzene's dangers, while finding its warning inadequate. Claims against other refiners, including Shell, Chevron, BP and U.S. Steel, were reported to be part of the same litigation. The sunscreen verdict ended on the first question of the verdict sheet without reaching causation, a result covered in the Neutrogena sunscreen benzene verdict analysis.

Taken together, the three results show that Philadelphia juries are not uniform on benzene. What Gill establishes is narrower and more durable: when a plaintiff wins and the defense has not preserved its causation objections, the appellate courts will not rescue the verdict.

What does the Gill ruling mean for other benzene lawsuits?

The ruling is not a Multidistrict Litigation (MDL) bellwether and does not bind any federal court, but it shapes valuation across the individual-case benzene docket that runs through Philadelphia and other state courts.

For claimants' counsel. The affirmance supports settlement demands in AML and other blood-cancer cases involving refinery products, solvents and service-station work, particularly in Philadelphia. It also shows the value of building a clean trial record: a verdict defended on preservation grounds is far harder to overturn than one defended on the merits of expert methodology.

For defendants and trial teams. The case is a preservation lesson. Causation objections should be pressed in motions in limine, at the close of evidence, in objections to the charge and in timely post-trial motions under Rule 227.1, in the same form they will take on appeal. Challenges to juror conduct must be raised within the 10-day post-trial window. Requests for a Frye hearing should be made explicitly and early.

For insurers. A judgment of this size, accruing interest at roughly $134,000 a day, puts pressure on excess and umbrella towers and on reserving for legacy exposure claims stretching back to the 1970s. The absence of punitive damages also means the award is not excluded from coverage on public-policy grounds in the way some punitive awards can be.

For funders and the PI bar generally. Large, purely compensatory Pennsylvania verdicts that survive appeal reinforce the jurisdiction's appeal for Third-Party Litigation Funding and for out-of-state plaintiffs whose exposure has a Pennsylvania connection. They also sharpen the legislative and judicial-election debate over noneconomic damages that the amici are pressing.

FAQ

What did the Pennsylvania Superior Court decide in Gill v. Exxon Mobil?

On October 15, 2026, a split three-judge panel affirmed the roughly $815.8 million judgment against ExxonMobil, finding most of its causation arguments waived, no abuse of discretion in admitting the plaintiffs' experts, and no error in the trial court's ruling that the award was not excessive.

How much is the Exxon benzene verdict worth now?

About $815.8 million: the jury's $725.5 million verdict plus about $90 million in Rule 238 delay damages, with post-judgment interest accruing on top at Pennsylvania's 6 percent legal rate.

Why did Exxon lose its appeal of the $816 million benzene judgment?

Mainly because it failed to preserve its key causation arguments in the trial court, and because the remaining challenges required the panel to find an abuse of discretion by the trial judge, which a majority declined to do.

Can Exxon appeal the benzene verdict to the Pennsylvania Supreme Court?

Yes. ExxonMobil can seek reargument in the Superior Court or file a petition for allowance of appeal with the Pennsylvania Supreme Court, ordinarily within 30 days of the October 15 decision, but the Supreme Court's review is discretionary.

Does the Gill ruling mean every benzene leukemia case will win?

No. A Philadelphia jury found largely for Exxon in the Mazza gasoline case on October 13, 2026, and another Philadelphia jury returned a defense verdict in the first Neutrogena benzene sunscreen trial in September 2026. Gill shows that a plaintiff's verdict built on a well-preserved record is difficult to overturn, not that liability is automatic.

Did the jury award punitive damages against Exxon?

No. The entire $725.5 million verdict was compensatory and noneconomic: $725 million for Paul Gill and $500,000 for Diane Gill's loss of consortium.